Procurement Summary
Country : USA
Summary : Methylphenidate Hcl Ir
Deadline : 08 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 96761078
Document Ref. No. : SPE2D2-24-R-0007
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Purchaser : DEPT OF DEFENSE
Contracting Office Address : PHILADELPHIA, PA 19111
Primary Point of Contact : Nancy Fernandez
nancy.fernandez@dla.mil
Phone Number 215-737-4955
Secondary Point of Contact : Catherine Gilbert
catherine.gilbert@dla.mil
Phone Number 215-737-4778
USA
Email :nancy.fernandez@dla.mil
Tender Details
Description
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Methylphenidate HCL IR. Procurement details follow.Methylphenidate HCL IR: 5MG, 10MG, and 20MG tablets in 100 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.gov at https://sam.gov. Interested parties should contact Nancy Fernandez (215) 737-4955, Nancy.Fernandez@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is March of 2024. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Active Contract Opportunity Notice ID SPE2D2-24-R-0007 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE LOGISTICS AGENCY Major Command TROOP SUPPORT MEDICAL Office DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Presolicitation (Updated)
All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Feb 08, 2024 04:36 pm EST
Original Published Date: Feb 08, 2024 01:13 pm EST
Updated Response Date:
Original Response Date:
Inactive Policy: Manual
Updated Inactive Date: Apr 08, 2024
Original Inactive Date: Apr 08, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance:
Documents
Tender Notice